Anna Abram

COVID-19, Regulatory Issues July 9, 2020

Partnering with the European Union and Global Regulators on COVID-19

By Anna Abram & Mark Abdoo – The European Union (EU) is one of the U.S. Food and Drug Administration’s most important collaborators in tackling public heath challenges. The FDA and the European Commission (EC) and its European Medicines Agency (EMA) have long leveraged each other’s expertise and experience…

Health Innovation December 11, 2018

FDA’s Global Efforts to Protect Patients and Consumers from Unsafe Products

By Anna Abram & Mark Abdoo – Even in this modern era, when so much can be done remotely, there are many tangible benefits to having “boots on the ground” when doing business overseas. That’s the thinking behind the FDA’s foreign offices, which play a vital role in inspecting….